BROOKSTONE CAPITAL MANAGEMENT – Halozyme Therapeutics, Inc. Transaction History
BROOKSTONE CAPITAL MANAGEMENT portfolio value:
$2.56M
portfolio value
BROOKSTONE CAPITAL MANAGEMENT quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.06% | -35 shares | -556K | $39.54 | 60.31K |
| Q2 2022 | share | Increase | +0.06% | 35 shares | 629K | $44 | 60.34K |
| Q1 2022 | share | 0.00% | 0 shares | 247K | $39.88 | 60.31K | |
| Q4 2021 | share | 0.00% | 0 shares | 24K | $40.32 | 60.31K | |
| Q3 2021 | share | 0.00% | 0 shares | -483K | $40.68 | 60.31K | |
| Q2 2021 | share | Increase | 0.00% | 60.31K shares | 2.70M | $45.41 | 60.31K |